$GILD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GILEAD SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GILEAD SCIENCES INC. Get notifications about new insider transactions in GILEAD SCIENCES INC for free.
Page: < prev 1 ... 30 31 32 33 34 35 36 37 38 ... 46 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 15 2007 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 68.79 | 1,800 | 123,822 | 13,700 | 15.5 K to 13.7 K (-11.61 %) |
| Mar 15 2007 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Buy | M | 4.78 | 6,500 | 31,078 | 15,500 | 9 K to 15.5 K (+72.22 %) |
| Mar 14 2007 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 2.86 | 35,000 | 100,079 | 210,392 | |
| Mar 14 2007 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 70.44 | 8,000 | 563,501 | 737,629 | 745.6 K to 737.6 K (-1.07 %) |
| Mar 14 2007 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 70.27 | 5,000 | 351,373 | 745,629 | 750.6 K to 745.6 K (-0.67 %) |
| Mar 14 2007 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 70.20 | 5,000 | 351,014 | 750,629 | 755.6 K to 750.6 K (-0.66 %) |
| Mar 14 2007 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 70.30 | 1,500 | 105,450 | 755,629 | 757.1 K to 755.6 K (-0.20 %) |
| Mar 14 2007 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 70.22 | 10,000 | 702,200 | 757,129 | 767.1 K to 757.1 K (-1.30 %) |
| Mar 14 2007 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 70.11 | 5,500 | 385,578 | 767,129 | 772.6 K to 767.1 K (-0.71 %) |
| Mar 14 2007 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 2.86 | 35,000 | 100,079 | 772,629 | 737.6 K to 772.6 K (+4.74 %) |
| Mar 08 2007 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 70.75 | 300 | 21,225 | 69,600 | 69.9 K to 69.6 K (-0.43 %) |
| Mar 08 2007 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 70.74 | 800 | 56,592 | 69,900 | 70.7 K to 69.9 K (-1.13 %) |
| Mar 08 2007 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 70.73 | 1,200 | 84,876 | 70,700 | 71.9 K to 70.7 K (-1.67 %) |
| Mar 08 2007 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 70.70 | 345 | 24,392 | 71,900 | 72.2 K to 71.9 K (-0.48 %) |
| Mar 08 2007 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 70.69 | 100 | 7,069 | 72,245 | 72.3 K to 72.2 K (-0.14 %) |
| Mar 08 2007 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 70.68 | 1,100 | 77,748 | 72,345 | 73.4 K to 72.3 K (-1.50 %) |
| Mar 08 2007 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 70.66 | 500 | 35,330 | 73,445 | 73.9 K to 73.4 K (-0.68 %) |
| Mar 08 2007 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Option Exercise | M | 6.77 | 16,400 | 110,957 | 55,600 | |
| Mar 08 2007 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Option Exercise | M | 5.13 | 23,600 | 121,136 | 0 | |
| Mar 08 2007 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 70.65 | 7,400 | 522,810 | 73,945 | 81.3 K to 73.9 K (-9.10 %) |
| Mar 08 2007 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 70.64 | 900 | 63,576 | 81,345 | 82.2 K to 81.3 K (-1.09 %) |
| Mar 08 2007 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 70.63 | 500 | 35,315 | 82,245 | 82.7 K to 82.2 K (-0.60 %) |
| Mar 08 2007 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 70.62 | 400 | 28,248 | 82,745 | 83.1 K to 82.7 K (-0.48 %) |
| Mar 08 2007 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 70.61 | 200 | 14,122 | 83,145 | 83.3 K to 83.1 K (-0.24 %) |
| Mar 08 2007 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 70.60 | 1,820 | 128,492 | 83,345 | 85.2 K to 83.3 K (-2.14 %) |
| Mar 08 2007 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 70.59 | 600 | 42,354 | 85,165 | 85.8 K to 85.2 K (-0.70 %) |
| Mar 08 2007 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 70.58 | 2,115 | 149,277 | 85,765 | 87.9 K to 85.8 K (-2.41 %) |
| Mar 08 2007 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 70.57 | 2,900 | 204,653 | 87,880 | 90.8 K to 87.9 K (-3.19 %) |
| Mar 08 2007 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 70.55 | 1,200 | 84,660 | 90,780 | 92 K to 90.8 K (-1.30 %) |
| Mar 08 2007 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 70.54 | 200 | 14,108 | 91,980 | 92.2 K to 92 K (-0.22 %) |
| Mar 08 2007 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 70.53 | 600 | 42,318 | 92,180 | 92.8 K to 92.2 K (-0.65 %) |
| Mar 08 2007 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 70.52 | 1,200 | 84,624 | 92,780 | 94 K to 92.8 K (-1.28 %) |
| Mar 08 2007 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 70.51 | 1,220 | 86,022 | 93,980 | 95.2 K to 94 K (-1.28 %) |
| Mar 08 2007 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 70.50 | 35 | 2,468 | 95,200 | 95.2 K to 95.2 K (-0.04 %) |
| Mar 08 2007 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 70.49 | 1,400 | 98,686 | 95,235 | 96.6 K to 95.2 K (-1.45 %) |
| Mar 08 2007 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 70.48 | 435 | 30,659 | 96,635 | 97.1 K to 96.6 K (-0.45 %) |
| Mar 08 2007 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 70.47 | 100 | 7,047 | 97,070 | 97.2 K to 97.1 K (-0.10 %) |
| Mar 08 2007 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 70.46 | 100 | 7,046 | 97,170 | 97.3 K to 97.2 K (-0.10 %) |
| Mar 08 2007 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 70.45 | 1,730 | 121,879 | 97,270 | 99 K to 97.3 K (-1.75 %) |
| Mar 08 2007 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 70.43 | 84 | 5,916 | 99,000 | 99.1 K to 99 K (-0.08 %) |
| Mar 08 2007 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 70.42 | 400 | 28,168 | 99,084 | 99.5 K to 99.1 K (-0.40 %) |
| Mar 08 2007 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 70.40 | 15 | 1,056 | 99,484 | 99.5 K to 99.5 K (-0.02 %) |
| Mar 08 2007 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 70.35 | 101 | 7,105 | 99,499 | 99.6 K to 99.5 K (-0.10 %) |
| Mar 08 2007 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Buy | M | 6.77 | 16,400 | 110,957 | 99,600 | 83.2 K to 99.6 K (+19.71 %) |
| Mar 08 2007 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Buy | M | 5.13 | 13,600 | 69,807 | 83,200 | 69.6 K to 83.2 K (+19.54 %) |
| Mar 08 2007 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Buy | M | 5.13 | 10,000 | 51,329 | 69,600 | 59.6 K to 69.6 K (+16.78 %) |
| Mar 02 2007 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Option Exercise | M | 13.60 | 4,750 | 64,612 | 20,112 | |
| Mar 02 2007 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 69.40 | 1,200 | 83,280 | 24,395 | 25.6 K to 24.4 K (-4.69 %) |
| Mar 02 2007 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 69.75 | 500 | 34,875 | 25,595 | 26.1 K to 25.6 K (-1.92 %) |
| Mar 02 2007 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 70.25 | 1,000 | 70,250 | 26,095 | 27.1 K to 26.1 K (-3.69 %) |
| Mar 02 2007 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 70.65 | 550 | 38,858 | 27,095 | 27.6 K to 27.1 K (-1.99 %) |
| Mar 02 2007 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 71.00 | 1,500 | 106,500 | 27,645 | 29.1 K to 27.6 K (-5.15 %) |
| Mar 02 2007 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Buy | M | 13.60 | 4,750 | 64,612 | 29,145 | 24.4 K to 29.1 K (+19.47 %) |
| Mar 01 2007 | GILD | GILEAD SCIENCES IN ... | Meyers James R | SVP Comm Ops North ... | Option Exercise | M | 9.34 | 3,000 | 28,031 | 15,712 | |
| Mar 01 2007 | GILD | GILEAD SCIENCES IN ... | Meyers James R | SVP Comm Ops North ... | Option Exercise | M | 7.08 | 3,000 | 21,235 | 0 | |
| Mar 01 2007 | GILD | GILEAD SCIENCES IN ... | Meyers James R | SVP Comm Ops North ... | Sell | S | 71.35 | 6,000 | 428,088 | 1,029 | 7 K to 1 K (-85.36 %) |
| Mar 01 2007 | GILD | GILEAD SCIENCES IN ... | Meyers James R | SVP Comm Ops North ... | Buy | M | 9.34 | 3,000 | 28,031 | 7,029 | 4 K to 7 K (+74.46 %) |
| Mar 01 2007 | GILD | GILEAD SCIENCES IN ... | Meyers James R | SVP Comm Ops North ... | Buy | M | 7.08 | 3,000 | 21,235 | 4,029 | 1 K to 4 K (+291.55 %) |
| Feb 27 2007 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Option Exercise | M | 13.60 | 20,000 | 272,050 | 19,148 | |
| Feb 27 2007 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 73.29 | 100 | 7,329 | 16,839 | 16.9 K to 16.8 K (-0.59 %) |
| Feb 27 2007 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 73.32 | 100 | 7,332 | 16,939 | 17 K to 16.9 K (-0.59 %) |
| Feb 27 2007 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 73.23 | 6,900 | 505,287 | 17,039 | 23.9 K to 17 K (-28.82 %) |
| Feb 27 2007 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 73.28 | 1,000 | 73,280 | 23,939 | 24.9 K to 23.9 K (-4.01 %) |
| Feb 27 2007 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 73.30 | 10,000 | 733,000 | 24,939 | 34.9 K to 24.9 K (-28.62 %) |
| Feb 27 2007 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 73.24 | 100 | 7,324 | 34,939 | 35 K to 34.9 K (-0.29 %) |
| Feb 27 2007 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 73.27 | 1,200 | 87,924 | 35,039 | 36.2 K to 35 K (-3.31 %) |
| Feb 27 2007 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 73.26 | 400 | 29,304 | 36,239 | 36.6 K to 36.2 K (-1.09 %) |
| Feb 27 2007 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 73.25 | 200 | 14,650 | 36,639 | 36.8 K to 36.6 K (-0.54 %) |
| Feb 27 2007 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Buy | M | 13.60 | 20,000 | 272,050 | 36,839 | 16.8 K to 36.8 K (+118.77 %) |
| Feb 26 2007 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Option Exercise | M | 9.81 | 16,184 | 158,765 | 56,640 | |
| Feb 26 2007 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Option Exercise | M | 7.40 | 3,816 | 28,233 | 0 | |
| Feb 26 2007 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 73.67 | 700 | 51,569 | 103,301 | 104 K to 103.3 K (-0.67 %) |
| Feb 26 2007 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 73.66 | 100 | 7,366 | 104,001 | 104.1 K to 104 K (-0.10 %) |
| Feb 26 2007 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 73.65 | 4,000 | 294,600 | 104,101 | 108.1 K to 104.1 K (-3.70 %) |
| Feb 26 2007 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 73.64 | 1,400 | 103,096 | 108,101 | 109.5 K to 108.1 K (-1.28 %) |
| Feb 26 2007 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 73.63 | 1,100 | 80,993 | 109,501 | 110.6 K to 109.5 K (-0.99 %) |
| Feb 26 2007 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 73.61 | 400 | 29,444 | 110,601 | 111 K to 110.6 K (-0.36 %) |
| Feb 26 2007 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 73.60 | 2,600 | 191,360 | 111,001 | 113.6 K to 111 K (-2.29 %) |
| Feb 26 2007 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 73.59 | 9,700 | 713,823 | 113,601 | 123.3 K to 113.6 K (-7.87 %) |
| Feb 26 2007 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Buy | M | 9.81 | 16,184 | 158,765 | 123,301 | 107.1 K to 123.3 K (+15.11 %) |
| Feb 26 2007 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Buy | M | 7.40 | 3,816 | 28,233 | 107,117 | 103.3 K to 107.1 K (+3.69 %) |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | MOORE GORDON EARLE | Director | Option Exercise | M | 3.28 | 16,000 | 52,501 | 0 | |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | MOORE GORDON EARLE | Director | Buy | M | 3.28 | 16,000 | 52,501 | 474,648 | 458.6 K to 474.6 K (+3.49 %) |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Option Exercise | M | 35.35 | 20,000 | 707,000 | 156,895 | |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Option Exercise | M | 32.02 | 10,000 | 320,200 | 74,670 | |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 72.33 | 2,800 | 202,524 | 1,974 | 4.8 K to 2 K (-58.65 %) |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 72.36 | 100 | 7,236 | 4,774 | 4.9 K to 4.8 K (-2.05 %) |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 72.28 | 2,400 | 173,472 | 4,874 | 7.3 K to 4.9 K (-32.99 %) |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 72.34 | 5,591 | 404,453 | 7,274 | 12.9 K to 7.3 K (-43.46 %) |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 72.32 | 1,668 | 120,630 | 12,865 | 14.5 K to 12.9 K (-11.48 %) |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 72.37 | 1,580 | 114,345 | 14,533 | 16.1 K to 14.5 K (-9.81 %) |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 72.26 | 1,000 | 72,260 | 16,113 | 17.1 K to 16.1 K (-5.84 %) |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 72.27 | 234 | 16,911 | 17,113 | 17.3 K to 17.1 K (-1.35 %) |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 72.31 | 500 | 36,155 | 17,347 | 17.8 K to 17.3 K (-2.80 %) |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 72.29 | 1,100 | 79,519 | 17,847 | 18.9 K to 17.8 K (-5.81 %) |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 72.30 | 400 | 28,920 | 18,947 | 19.3 K to 18.9 K (-2.07 %) |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 72.23 | 731 | 52,800 | 19,347 | 20.1 K to 19.3 K (-3.64 %) |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 72.25 | 1,728 | 124,848 | 20,078 | 21.8 K to 20.1 K (-7.92 %) |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 72.24 | 10,168 | 734,536 | 21,806 | 32 K to 21.8 K (-31.80 %) |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Buy | M | 35.35 | 20,000 | 707,000 | 31,974 | 12 K to 32 K (+167.03 %) |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Buy | M | 32.02 | 10,000 | 320,200 | 11,974 | 2 K to 12 K (+506.59 %) |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Sell | S | 73.79 | 2,200 | 162,338 | 166,381 | 168.6 K to 166.4 K (-1.31 %) |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Sell | S | 73.73 | 200 | 14,746 | 168,581 | 168.8 K to 168.6 K (-0.12 %) |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Sell | S | 73.70 | 2,300 | 169,510 | 168,781 | 171.1 K to 168.8 K (-1.34 %) |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Sell | S | 73.78 | 400 | 29,512 | 171,081 | 171.5 K to 171.1 K (-0.23 %) |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Sell | S | 73.74 | 300 | 22,122 | 171,481 | 171.8 K to 171.5 K (-0.17 %) |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Sell | S | 73.71 | 14,600 | 1,076,166 | 171,781 | 186.4 K to 171.8 K (-7.83 %) |
| Feb 20 2007 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Option Exercise | M | 7.41 | 32,000 | 237,002 | 0 | |
| Feb 20 2007 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Option Exercise | M | 7.41 | 20,000 | 148,126 | 32,000 | |
| Feb 20 2007 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Sell | S | 72.50 | 631 | 45,748 | 58,399 | 59 K to 58.4 K (-1.07 %) |
| Feb 20 2007 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Sell | S | 72.00 | 1,100 | 79,200 | 59,030 | 60.1 K to 59 K (-1.83 %) |
| Feb 20 2007 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Sell | S | 71.99 | 5,915 | 425,821 | 60,130 | 66 K to 60.1 K (-8.96 %) |
| Feb 20 2007 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Sell | S | 71.98 | 2,700 | 194,346 | 66,045 | 68.7 K to 66 K (-3.93 %) |
| Feb 20 2007 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Sell | S | 71.97 | 1,000 | 71,970 | 68,745 | 69.7 K to 68.7 K (-1.43 %) |
| Feb 20 2007 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Sell | S | 71.96 | 2,700 | 194,292 | 69,745 | 72.4 K to 69.7 K (-3.73 %) |
| Feb 20 2007 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Sell | S | 71.95 | 3,956 | 284,634 | 72,445 | 76.4 K to 72.4 K (-5.18 %) |
| Feb 20 2007 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Sell | S | 71.94 | 2,550 | 183,447 | 76,401 | 79 K to 76.4 K (-3.23 %) |
| Feb 20 2007 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Sell | S | 71.93 | 2,351 | 169,107 | 78,951 | 81.3 K to 79 K (-2.89 %) |
| Feb 20 2007 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Sell | S | 71.92 | 1,119 | 80,478 | 81,302 | 82.4 K to 81.3 K (-1.36 %) |
| Feb 20 2007 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Sell | S | 71.91 | 3,200 | 230,112 | 82,421 | 85.6 K to 82.4 K (-3.74 %) |
| Feb 20 2007 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Sell | S | 71.90 | 4,778 | 343,538 | 85,621 | 90.4 K to 85.6 K (-5.29 %) |
| Feb 20 2007 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Buy | M | 7.41 | 32,000 | 237,002 | 90,399 | 58.4 K to 90.4 K (+54.80 %) |
| Feb 20 2007 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Sell | S | 72.05 | 2,353 | 169,534 | 58,399 | 60.8 K to 58.4 K (-3.87 %) |
| Feb 20 2007 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Sell | S | 72.02 | 2,500 | 180,050 | 60,752 | 63.3 K to 60.8 K (-3.95 %) |
| Feb 20 2007 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Sell | S | 72.03 | 200 | 14,406 | 63,252 | 63.5 K to 63.3 K (-0.32 %) |
| Feb 20 2007 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Sell | S | 72.06 | 500 | 36,030 | 63,452 | 64 K to 63.5 K (-0.78 %) |
| Feb 20 2007 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Sell | S | 72.04 | 2,632 | 189,609 | 63,952 | 66.6 K to 64 K (-3.95 %) |
| Feb 20 2007 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Sell | S | 72.00 | 11,815 | 850,680 | 66,584 | 78.4 K to 66.6 K (-15.07 %) |
| Feb 20 2007 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Buy | M | 7.41 | 20,000 | 148,126 | 78,399 | 58.4 K to 78.4 K (+34.25 %) |
| Feb 15 2007 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 2.86 | 35,000 | 100,079 | 245,392 | |
| Feb 15 2007 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 70.71 | 9,000 | 636,416 | 737,629 | 746.6 K to 737.6 K (-1.21 %) |
| Feb 15 2007 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 70.68 | 6,000 | 424,067 | 746,629 | 752.6 K to 746.6 K (-0.80 %) |
| Feb 15 2007 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 70.79 | 6,000 | 424,760 | 752,629 | 758.6 K to 752.6 K (-0.79 %) |
| Feb 15 2007 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 70.95 | 4,000 | 283,802 | 758,629 | 762.6 K to 758.6 K (-0.52 %) |
| Feb 15 2007 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 71.04 | 6,000 | 426,263 | 762,629 | 768.6 K to 762.6 K (-0.78 %) |
| Feb 15 2007 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 71.13 | 4,000 | 284,504 | 768,629 | 772.6 K to 768.6 K (-0.52 %) |
| Feb 15 2007 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 2.86 | 35,000 | 100,079 | 772,629 | 737.6 K to 772.6 K (+4.74 %) |
| Feb 12 2007 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Option Exercise | M | 16.44 | 133,920 | 2,201,310 | 0 | |
| Feb 12 2007 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Option Exercise | M | 16.44 | 6,080 | 99,940 | 0 | |
| Feb 12 2007 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 71.20 | 80,000 | 5,696,000 | 525,381 | 605.4 K to 525.4 K (-13.21 %) |
| Feb 12 2007 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 71.25 | 20,000 | 1,425,000 | 605,381 | 625.4 K to 605.4 K (-3.20 %) |
| Feb 12 2007 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 71.30 | 10,000 | 713,000 | 625,381 | 635.4 K to 625.4 K (-1.57 %) |
| Feb 12 2007 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 71.33 | 23,920 | 1,706,214 | 635,381 | 659.3 K to 635.4 K (-3.63 %) |
| Feb 12 2007 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Buy | M | 16.44 | 140,000 | 2,301,250 | 659,301 | 519.3 K to 659.3 K (+26.96 %) |
| Feb 07 2007 | GILD | GILEAD SCIENCES IN ... | DAVIGNON ETIENNE | Director | Sell | S | 69.95 | 19,000 | 1,329,069 | 238,250 | 257.3 K to 238.3 K (-7.39 %) |
| Feb 07 2007 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Sell | S | 70.22 | 15,900 | 1,116,498 | 186,381 | 202.3 K to 186.4 K (-7.86 %) |
| Feb 07 2007 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Sell | S | 70.24 | 4,100 | 287,984 | 202,281 | 206.4 K to 202.3 K (-1.99 %) |
| Feb 02 2007 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Option Exercise | M | 13.60 | 20,650 | 280,892 | 24,862 | |
| Feb 02 2007 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 69.90 | 2,400 | 167,760 | 24,395 | 26.8 K to 24.4 K (-8.96 %) |
| Feb 02 2007 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 70.00 | 14,700 | 1,029,000 | 26,795 | 41.5 K to 26.8 K (-35.43 %) |